PC3 Platform for Respiratory and Vector-Borne Viruses

The QIMR Berghofer Emerging Viral Diseases Laboratory is one of the few Australian institutes offering contract R&D for high-containment respiratory and vector-borne viruses in our certified, state-of-the-art PC3 Facility. We provide in vivo and in vitro studies designed and customised to meet your specific research needs, supporting the development of antivirals, vaccines, and immunomodulators from early discovery through to IND-enabling studies.

Our virus and disease mouse models are designed to closely mimic human disease progression and have supported multiple high-impact programs advancing to non-human primate studies, clinical trials, and veterinary applications. Complementing our PC3 capabilities, we provide a comprehensive portfolio of PC2 models for vector-borne viruses as outlined in the table below.